Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Active not recruiting 5Completed 4Unknown 3Terminated 3Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Urinary Bladder Neoplasms 7Peritoneal Neoplasms 4Non-Muscle Invasive Bladder Neoplasms 4Colorectal Neoplasms 3Carcinoma, Transitional Cell 3Appendiceal Neoplasms 3Urologic Neoplasms 2Urogenital Neoplasms 2Stomach Neoplasms 2Recurrence 2Pseudomyxoma Peritonei 2Ovarian Neoplasms 2Neoplasms by Site 2Neoplasms 2Anus Neoplasms 2Uterine Neoplasms 1Urologic Diseases 1Urogenital Diseases 1Urinary Bladder Diseases 1Sarcoma 1Pleural Neoplasms 1Neoplasms by Histologic Type 1Neoplasm Metastasis 1Necrosis 1Mediastinal Neoplasms 1Male Urogenital Diseases 1Gastrointestinal Neoplasms 1Female Urogenital Diseases 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Radiotherapy 4pembrolizumab 2aldesleukin 2Specimen Handling 2Radiation 2Mitomycin 2Drug Therapy 2Capecitabine 2Adoptive Transfer 2trastuzumab deruxtecan 1spartalizumab 1fludarabine 1Tomography, X-Ray Computed 1Surveys and Questionnaires 1Restraint, Physical 1Radiotherapy, Intensity-Modulated 1Positron-Emission Tomography 1Parturition 1Paclitaxel 1Nivolumab 1Magnetic Resonance Spectroscopy 1Induction Chemotherapy 1Immune Checkpoint Inhibitors 1Human Papillomavirus DNA Tests 1Fluorouracil 1Fluorodeoxyglucose F18 1FAPI-46 1Diagnostic Tests, Routine 1Dehydroepiandrosterone 1Cytological Techniques 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Anus Neoplasms × Mitomycin × Clear all
NCT05838391 2026-02-03

Adaptive Radiation in Anal Cancer

Columbia University

Phase NA Recruiting
20 enrolled
Gastrointestinal

Anus Neoplasms

NCT06207981 2025-09-02

KANALRAD

Federation Francophone de Cancerologie Digestive

Phase 3 Recruiting
310 enrolled
Gastrointestinal

Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡